Tarun Gandhi, aged 38 years, is the Promoter, Chairman and Managing Director of our Company. He holds a bachelor's degree in commerce (advanced financial accounting and management accounting) with honours from Bangalore University. In the past, he was associated with M/s. Amwill Healthcare in the capacity of pharmaceutical business manager, and was heading the purchase, accounts and financing division. Subsequent to the transfer of business of M/s. Amwill Healthcare to our Company, he was appointed as the Director of our Company, since its incorporation. He was responsible for overseeing the finance, accounts and business development of our Company. He has been designated as the Managing Director of our Company with effect from January 27, 2024. He is also a partner in Amderma Healthcare LLP, Ample Pharma and Ayodhya Heritage Developers LLP. He holds experience of more than a decade in financial management, accounts management and business development. Presently, he heads the product development, business development and finance and accounts divisions of our Company. Anand Gandhi, aged 39 years, is the Promoter and Managing Director of our Company. He holds a bachelor's and master's degree in pharmacy (pharmaceutics) with honours from Rajiv Gandhi University of Health Sciences, Karnataka. He was the proprietor of M/s. Amwill Healthcare, and was responsible for overseeing the marketing and sales division of the proprietorship. Subsequent to the transfer of business of M/s. Amwill Healthcare to our Company, he was appointed as the Director of our Company, since its incorporation. He has been designated as the Managing Director of our Company with effect from January 27, 2024. He is also a partner in Amderma Healthcare LLP, Ample Pharma and Ayodhya Heritage Developers LLP. He holds experience of more than a decade in brand placement, marketing and sales and enhancing product visibility in the dermatology segment of the pharmaceutical industry. Presently, he heads the marketing and sales, dermatologist relations divisions of our Company. Rekha Jagadish aged 44 years, is a Non- Executive Director of our Company. She holds a bachelor's degree in dental surgery from Rajiv Gandhi University of Health Sciences. She also holds a master's degree in dental surgery (periodontics) from Rajiv Gandhi University of Health Sciences, Karnataka. She has been associated with Rajya Vokkaligara Sangha Dental College & Hospital in the capacity of a reader in their periodontics department. She is the sole proprietor of Skin Care Pharma, which is engaged in the business of trading of pharmacy products, including dermatology products. She is also associated with Roots Associates, in the capacity of its partner, which is engaged in the business of organizing conferences and seminars for various sectors. She has experience of more than a decade as a medical professional and a lecturer. She has been associated with our Company since December 28, 2023. Sambhav Mehta, aged 31 years, is an Independent Director of our Company. He holds a bachelor's degree in commerce from Jain University. He attended School of Commerce and Management Studies, Jain University to pursue a certified program in general management from Jain University. He is currently pursuing LLB from BMS College of Law, Karnataka State Law University. He is a fellow member of the Institute of Chartered Accountants of India ("ICAI"), and also holds a certificate of practice issued by ICAI. He is also associated with MGIRT & Co, Chartered Accountants. In the past, he was associated with Ernst & Young LLP in the capacity of a senior consultant in tax practice. He has more than five years of experience in taxation and accounting. He has been associated with our Company since January 04, 2024. Sagar Goutam Nahar, aged 33 years, is an Independent Director of our Company. He holds a bachelor's degree in arts and a bachelor's degree in law from Karnataka State Law University, Hubbali. He is enrolled as an advocate with the Karnataka State Bar Council and the Bar Council of India and has an experience of more than five years. He has been associated with our Company since January 27, 2024.

A. None of the above-mentioned Directors are on the RBI List of wilful defaulters or Fraudulent Borrowers. B. Neither Promoters nor persons forming part of our Promoter Group, our directors or persons in control of our

Company or our Company are debarred from accessing the capital market by SEBI.

C. None of the Promoters, Directors or persons in control of our Company, has been or is involved as a promoter, director or person in control of any other company, which is debarred from accessing the capital market under any order or directions made by SEBI or any other regulatory authority. D. None of our Directors are/were director of any company whose shares were delisted from any stock exchange(s) during his/her tenure. E. None of Promoters or Directors of our Company are a fugitive economic offender.

F. None of our Directors are/were director of any company whose shares were suspended from trading by stock exchange(s) or under any order or directions issued by the stock exchange(s)/ SEBI/ other regulatory authority in the last five years. G. In respect of the track record of the directors, there have been no criminal cases filed or investigations being undertakenwith regard to alleged commission of any offence by any of our directors and none of our directors have been charge- sheeted with serious crimes like murder, rape, forgery, economic offence.

Except for Anand Gandhi who is the brother of Tarun Gandhi, none of our Directors are related to each other.

None of our Key Managerial Personnel, Senior Management or Directors have been appointed pursuant to any arrangement or understanding with our major shareholders, customers, suppliers or others pursuant to which any of the directors was selected as a director or member of senior management.

Except as stated otherwise in this Draft Red Herring Prospectus and any statutory payments made by our Company, no non-salary amount or benefit has been paid, in two preceding years, or given or is intended to be paid or given to any of our Company's officers except remuneration of services rendered as Directors, officers or employees of our Company.

Other than the statutory benefits that the KMPs are entitled to, upon their retirement, Directors and the Key Managerial Personnel of our Company have not entered into any service contracts pursuant to which they are entitled to any benefits upon termination of employment or retirement.

Our Articles of Association, subject to applicable law, authorize our Board to raise or borrow money or secure the payment of any sum of money for the purposes of our Company. Our Company has, pursuant to a resolution passed by the Shareholders at an extra ordinary general meeting held on December 29, 2023, authorised our Board to borrow from time to time, any sum or sums of monies which together with the monies already borrowed by our Company (apart from temporary loans obtained or to be obtained from our Company's bankers in the ordinary course of business) may exceed the aggregate of the paid up capital of our Company and its free reserves provided that the total amount so borrowed by the Board shall not at any time exceed 2,500.00 lakhs or the aggregate of the paid up capital and free reserves of our Company, whichever is higher.

Pursuant to a resolution passed by the Board of Directors at the meeting held on January 25, 2024 and approved by the Shareholders of our Company at an EGM held on January 27, 2024, Anand Gandhi was designated as the Managing Director of our Company for a period of three (3) years with effect from January 27, 2024 along with the terms of remuneration, in accordance with Sections 196, 197, 203 and Schedule V and other relevant provisions of the Companies Act, 2013 read with the rules prescribed thereunder. The terms and conditions approved by the Board of Directors and the Shareholders have been summarised below:

Pursuant to a resolution passed by the Board of Directors at the meeting held on January 25, 2024 and approved by the Shareholders of our Company at the EGM held on January 27, 2024, Tarun Gandhi was designated as the Managing Director of our Company for a period of three (3) years with effect from January 27, 2024 along with the terms of remuneration, in accordance with Sections 196, 197, 203 and Schedule V and other relevant provisions of the Companies Act, 2013 read with the rules prescribed thereunder. The terms and conditions approved by the Board of Directors and the Shareholders have been summarised below:

The aggregate value of the remuneration paid to the Executive Directors in Fiscal 2024 is as follows:

Our Executive Directors were not paid sitting fee in Fiscal 2024 for attending meetings of the Board of Directors and its committees.

Our Board of Directors in their meeting held on January 27, 2024 have fixed 10,000/- as sitting fee for Independent Directors and Non-Executive Directors, for attending meetings of the Board of Directors and its committees.

Except as disclosed in this Draft Red Herring Prospectus, no amount or benefit has been paid or given within the two preceding years or is intended to be paid or given to any of the Executive Directors except the normal remuneration for services rendered as a Director of our Company. Additionally, there is no contingent or deferred compensation payable to any of our Directors.

As on the date of this Draft Red Herring Prospectus, our Company does not have a subsidiary.

There are no loans that have been availed by the Directors from our Company that are outstanding as on the date of this Draft Red Herring Prospectus.

Except as stated below, none of our Directors holds any Equity Shares of our Company as on the date of filing of this Draft Red Herring Prospectus:

Our Articles of Association do not require our Directors to hold any qualification Equity Shares in the Company.

Our Executive Directors may be deemed to be interested to the extent of remuneration paid to them for services rendered as a Director of our Company and reimbursement of expenses, if any, payable to them. For details of remuneration paid to our see "Terms of appointment and remuneration of our Executive Directors" above. Our Managing Directors, Tarun Gandhi and Anand Gandhi have received professional fee during the nine month period ended December 31, 2023 and the Financial Years ended March 31, 2023, March 31, 2022 and March 31, 2021, for empanelling medical experts and doctors, for the purpose of advising on the products proposed to be developed by our Company. Further, Bhavya Gandhi, the sister of our Managing Directors, Anand Gandhi and Tarun Gandhi, has received professional fee during the nine month period ended December 31, 2023 and the Financial Year ended March 31, 2023, for offering financial and accounting consultancy to our Company. Our Directors may also be interested to the extent of Equity Shares, if any, held by them or held by the entities in which they are associated as promoters, directors, partners, proprietors or trustees or kartas or coparceners or held by their relatives or that may be subscribed by or allotted to the companies, firms, ventures, trusts in which they are interested as promoters, directors, partners, proprietors, members or trustees, pursuant to this Offer. Except as disclosed in "Financial Information" and "Our Promoters and Promoter Group" beginning on Page Nos. 181 and 175, respectively of this Draft Red Herring Prospectus, our Directors are not interested in any other company, entity or firm. Except as stated in "Restated Financial Information – Note 30 - Related party disclosures" from the chapter titled

"Restated Financial Information" on Page No. 181 of this Draft Red Herring Prospectus, our Directors do not have any other interest in the business of our Company.

Except as mentioned in "Our Business - Land and Property" and "Restated Financial Information – Note 30 - Related party disclosures" from the chapter titled "Restated Financial Information" on Page No. 181 of this Draft Red Herring Prospectus, our Directors do not have any interest in any property acquired or proposed to be acquired by our Company.

None of our Directors are a party to any bonus or profit sharing plan.

Except as disclosed below, there have been no changes in our Board during the last three years.

Set forth is the management organization structure of our Company:

As our Company is coming with an issue in terms of Chapter IX of the SEBI (ICDR) Regulations, 2018 as amended from time to time, as on date of this Draft Red Herring Prospectus, the requirement specified in regulations 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 and clauses (b) to (i) of sub-regulation (2) of regulation 46 and para C, D and E of Schedule V of SEBI (LODR) Regulations, 2015 are not applicable to our Company. In additions to the applicable provisions of the Companies Act, 2013 will be applicable to our company immediately up on the listing of Equity Shares on the Stock Exchanges. However, our Company has complied with the corporate governance requirement, particularly in relation to appointment of independent directors including woman director on our Board, constitution of an Audit Committee and Nomination and Remuneration Committee. Our Board functions either on its own or through committees constituted thereof, to oversee specific operational areas.

Our Board has constituted following committees in accordance with the requirements of the Companies Act and SEBI Listing Regulations: a) Audit Committee; b) Stakeholders' Relationship Committee; c) Nomination and Remuneration Committee; and d) Corporate Social Responsibility Committee. Details of each of these committees are as follows:

The Audit Committee was constituted vide Board resolution dated March 4, 2024 pursuant to Section 177 of the Companies Act, 2013. As on the date of this Draft Red Herring Prospectus, the Audit Committee comprises of:

Our Company Secretary and Compliance Officer acts as the secretary of the Company.

The scope of the Audit Committee shall include but shall not be restricted to the following:

The Audit Committee shall be responsible for, among other things, as may be required by the stock exchange from time to time, the following:

The Audit Committee shall have powers, including the following: 1. to investigate any activity within its terms of reference; 2. to seek information from any employee;

3. to obtain outside legal or other professional advice;

4. to secure attendance of outsiders with relevant expertise, if it considers necessary; and

5. such other powers as may be prescribed under the Companies Act and SEBI Listing Regulations.

The role of the Audit Committee shall include the following:

(1) oversight of financial reporting process and the disclosure of financial information relating to the Company to ensure that the financial statements are correct, sufficient and credible; (2) recommendation for appointment, re-appointment, replacement, remuneration and terms of appointment of auditors of the Company and the fixation of the audit fee; (3) approval of payment to statutory auditors for any other services rendered by the statutory auditors; (4) formulation of a policy on related party transactions, which shall include materiality of related party transactions; (5) reviewing, at least on a quarterly basis, the details of related party transactions entered into by the Company pursuant to each of the omnibus approvals given; (6) examining and reviewing, with the management, the annual financial statements and auditor's report thereon before submission to the Board for approval, with particular reference to: a. Matters required to be included in the director's responsibility statement to be included in the Board's report in terms of clause (c) of sub-section 3 of section 134 of the Companies Act, 2013; b. Changes, if any, in accounting policies and practices and reasons for the same; c. Major accounting entries involving estimates based on the exercise of judgment by management; d. Significant adjustments made in the financial statements arising out of audit findings; e. Compliance with listing and other legal requirements relating to financial statements; f. Disclosure of any related party transactions; and g. Modified opinion(s) in the draft audit report.

(7) reviewing, with the management, the quarterly, half-yearly and annual financial statements before submission to the Board for approval;

(8) reviewing, with the management, the statement of uses / application of funds raised through an issue (public issue, rights issue, preferential issue, etc.), the statement of funds utilised for purposes other than those stated in the Issue document / prospectus / notice and the report submitted by the monitoring agency monitoring the utilisation of proceeds of a public or rights issue, and making appropriate recommendations to the board of directors of the Company (the "Board" or "Board of Directors") to take up steps in this matter; (9) reviewing and monitoring the auditor's independence and performance, and effectiveness of audit process; (10) approval of any subsequent modification of transactions of the Company with related parties and omnibus approval for related party transactions proposed to be entered into by the Company, subject to the conditions as may be prescribed;

(11) scrutiny of inter-corporate loans and investments;

(12) valuation of undertakings or assets of the Company, wherever it is necessary; (13) evaluation of internal financial controls and risk management systems;

(14) reviewing, with the management, performance of statutory and internal auditors, adequacy of the internal control systems; (15) reviewing the adequacy of internal audit function, if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure coverage and frequency of internal audit; (16) discussion with internal auditors of any significant findings and follow up there on; (17) reviewing the findings of any internal investigations by the internal auditors into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to the Board (18) discussion with statutory auditors before the audit commences, about the nature and scope of audit as well as post-audit discussion to ascertain any area of concern; (19) recommending to the board of directors the appointment and removal of the external auditor, fixation of audit fees and approval for payment for any other services; (20) monitoring the end use of funds raised through public offers and related matters; (21) looking into the reasons for substantial defaults in the payment to depositors, debenture holders, shareholders (in case of non-payment of declared dividends) and creditors; (22) reviewing the functioning of the whistle blower mechanism; (23) monitoring the end use of funds raised through public offers and related matters; (24) overseeing the vigil mechanism established by the Company, with the chairman of the Audit Committee directly hearing grievances of victimization of employees and directors, who used vigil mechanism to report genuine concerns in appropriate and exceptional cases; (25) approval of appointment of chief financial officer (i.e., the whole-time finance Director or any other person heading the finance function or discharging that function) after assessing the qualifications, experience and background, etc. of the candidate; (26) reviewing the utilization of loans and/or advances from/investment by the holding company in the subsidiary exceeding 1,000,000,000 or 10% of the asset size of the subsidiary, whichever is lower including existing loans/ advances/ investments existing as on the date of coming into force of this provision;

(27) To formulate, review and make recommendations to the Board to amend the Terms of Reference of Audit Committee from time to time; (28) consider and comment on rationale, cost-benefits and impact of schemes involving merger, demerger, amalgamation etc., on the Company and its shareholders; and (29) carrying out any other functions required to be carried out by the Audit Committee as contained in the SEBI Listing Regulations, Companies Act, 2013, uniform listing agreements and/or any other applicable law, as and when amended from time to time." The Audit Committee shall mandatorily review the following information:

1. Management discussion and analysis of financial condition and results of operations;

2. Management letters / letters of internal control weaknesses issued by the statutory auditors;

3. Internal audit reports relating to internal control weaknesses;

4. The appointment, removal and terms of remuneration of the chief internal auditor;

5. Statement of deviations in terms of the SEBI Listing Regulations: a. quarterly statement of deviation(s) including report of monitoring agency, if applicable, submitted to stock exchange(s)where the Equity Shares are proposed to be listed in terms of the SEBI Listing Regulations; and b. annual statement of funds utilised for purposes other than those stated in the offer document/prospectus/notice in terms of the SEBI Listing Regulations. 6. review the financial statements, in particular, the investments made by any unlisted subsidiary;

7. Such information as may be prescribed under the Companies Act and SEBI Listing Regulations.

The Audit Committee shall meet at least four times a year with maximum interval of four months between two meetings, and shall have the authority to investigate into any matter in relation to the items specified under the terms of reference or such other matter as may be referred to it by the Board and for this purpose, shall have full access to information contained in the records of the Company and shall have power to seek information from any employee, obtain external professional advice, and secure attendance of outsiders with relevant expertise if necessary.

The Stakeholders' Relationship Committee was constituted by the Board of Directors vide resolution dated March 4, 2024. As on the date of this Draft Red Herring Prospectus, the Audit Committee comprises of:

Our Company Secretary and Compliance Officer acts as the secretary of the Company.

The scope of the Stakeholders' Relationship Committee shall include but shall not be restricted to the following: (1) Resolving the grievances of the security holders of the Company including complaints related to transfer/transmission of shares, non-receipt of annual report, non-receipt of declared dividends, issue of new/duplicate certificates, general meetings etc; (2) Review of measures taken for effective exercise of voting rights by shareholders; (3) Review of adherence to the service standards adopted by the Company in respect of various services being rendered by the Registrar and Share Transfer Agent; and (4) Considering and specifically looking into various aspects of interest of shareholders, debenture holders and other security holders; (5) Investigating complaints relating to allotment of shares, approval of transfer or transmission of shares, debentures or any other securities; (6) Giving effect to all transfer/transmission of shares and debentures, dematerialisation of shares and re-materialisation of shares, split and issue of duplicate/consolidated share certificates, compliance with all the requirements related to shares, debentures and other securities from time to time; (7) Review of the various measures and initiatives taken by the Company for reducing the quantum of unclaimed dividends and ensuring timely receipt of dividend warrants/annual reports/statutory notices by the shareholders of the Company.

(8) Carrying out such other functions as may be specified by the Board from time to time or specified/provided under the Companies Act or SEBI Listing Regulations, or by any other regulatory authority. (9) To approve, register, refuse to register transfer or transmission of shares and other securities; (10) To sub-divide, consolidate and or replace any share or other securities certificate(s) of the Company; (11) Allotment and listing of shares; (12) To authorise affixation of common seal of the Company; (13) To issue duplicate share or other security(ies) certificate(s) in lieu of the original share/security(ies) certificate(s) of the Company; (14) To approve the transmission of shares or other securities arising as a result of death of the sole/any joint shareholder; (15) Carrying out any other functions contained in the Companies Act, 2013 and/or equity listing agreements (if applicable), as and when amended from time to time; and (16) To further delegate all or any of the power to any other employee(s), officer(s), representative(s), consultant(s), professional(s), or agent(s). The Stakeholders Relationship Committee shall meet at least once in a year. The Chairperson of the Stakeholders Relationship Committee shall be present at general meetings of the Company, or in the absence of the Chairperson, any other member of the Stakeholders Relationship Committee authorised by the Chairperson in this behalf.

The Nomination and Remuneration Committee was constituted at a meeting of the Board of Directors held on March 4, 2024. As on the date of this Draft Red Herring Prospectus, the Audit Committee comprises of:

Our Company Secretary and Compliance Officer acts as the secretary of the Company.

The scope of the Nomination and Remuneration Committee shall include but shall not be restricted to the following: (1) Formulation of the criteria for determining qualifications, positive attributes and independence of a director and recommend to the board of directors of the Company (the "Board" or "Board of Directors") a policy relating to the remuneration of the directors, key managerial personnel and other employees ("Remuneration Policy"). For every appointment of an independent director, the Nomination and Remuneration Committee shall evaluate the balance of skills, knowledge and experience on the Board and on the basis of such evaluation, prepare a description of the role and capabilities required of an independent director. The person recommended to the Board for appointment as an independent director shall have the capabilities identified in such description. For the purpose of identifying suitable candidates, the Committee may: a. use the services of an external agencies, if required;

b. consider candidates from a wide range of backgrounds, having due regard to diversity; and c. consider the time commitments of the candidates.

The Nomination and Remuneration Committee, while formulating the above policy, should ensure that:

(i) the level and composition of remuneration be reasonable and sufficient to attract, retain and motivate directors of the quality required to run our Company successfully; (ii) relationship of remuneration to performance is clear and meets appropriate performance benchmarks; and

(iii) remuneration to directors, key managerial personnel and senior management involves a balance between fixed and incentive pay reflecting short- and long-term performance objectives appropriate to the working of the Company and its goals. (2) Formulation of criteria for evaluation of the performance of the independent directors and the Board; (3) Devising a policy on Board diversity; (4) Identifying persons who are qualified to become directors and who may be appointed in senior management in accordance with the criteria laid down, and recommend to the Board their appointment and removal and shall specify the manner for effective evaluation of performance of Board, its committees and individual directors to be carried out either by the Board, by the Nomination and Remuneration Committee or by an independent external agency and review its implementation and compliance. (5) Determining whether to extend or continue the term of appointment of the independent director, on the basis of the report of performance evaluation of independent directors; (6) To recommend, implement, design, execute, approve schemes of ESPS, ESOP, SAR, Sweat Equity and do all other activities. (7) Recommend to the board, all remuneration, in whatever form, payable to senior management; (8) Carrying out any other functions required to be carried out by the Nomination and Remuneration Committee as contained in the SEBI Listing Regulations or any other applicable law, as and when amended from time to time." (9) Analysing, monitoring and reviewing various human resource and compensation matters; (10) Deciding whether to extend or continue the term of appointment of the independent director, on the basis of the report of performance evaluation of independent directors; (11) Determining the Company's policy on specific remuneration packages for executive directors including pension rights and any compensation payment, and determining remuneration packages of such directors; (12) Recommending to the board, all remuneration, in whatever form, payable to senior management and other staff, as deemed necessary; (13) Administering, monitoring and formulating detailed terms and conditions of the employee stock option scheme, if any, of the Company; (14) Reviewing and approving the Company's compensation strategy from time to time in the context of the then current Indian market in accordance with applicable laws; (15) Performing such functions as are required to be performed by the compensation committee under the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, if applicable; (16) Framing suitable policies, procedures and systems to ensure that there is no violation of securities laws, as amended from time to time, including: (a) the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015; and (b) the Securities and Exchange Board of India (Prohibition of Fraudulent and Unfair Trade Practices Relating to the Securities Market) Regulations, 2003, by the trust, the Company and its employees, as applicable; and (17) Performing such other activities as may be delegated by the Board or specified/ provided under the Companies Act, 2013 to the extent notified and effective, as amended or by the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended or by any other applicable law or regulatory authority. (18) For every appointment of an independent director, the Nomination and Remuneration Committee shall evaluate the balance of skills, knowledge and experience on the Board and on the basis of such evaluation, prepare a description of the role and capabilities required of an independent director. The person recommended to the Board for appointment as an independent director shall have the capabilities identified in such description. For the purpose of identifying suitable candidates, the Committee may: 1. use the services of an external agencies, if required;

2. consider candidates from a wide range of backgrounds, having due regard to diversity; and 3. consider the time commitments of the candidates.

The quorum for a meeting of the Nomination and Remuneration Committee shall either be two members or one-third of the members of the Nomination and Remuneration Committee, whichever is greater, with at least one independent director present. The Nomination and Remuneration Committee shall meet at least once in a year. The Chairperson of the Nomination and Remuneration Committee shall be present at general meetings of the Company to answer the shareholders' queries, however, it shall be up to the chairperson to decide who shall answer the queries. In the absence of the Chairperson, any other member of the Nomination and Remuneration Committee may be authorised by the Chairperson in this behalf.

The Corporate Social Responsibility Committee was constituted at a meeting of the Board of Directors held on January 27, 2024. As on the date of this Draft Red Herring Prospectus, the Audit Committee comprises of:

The scope of the Corporate Social Responsibility Committee shall include but shall not be restricted to the following:

1. To formulate and recommend to the Board, a CSR policy which will indicate the activities to be undertaken by the Company in accordance with Schedule VII of the Companies Act, 2013;

2. To review and recommend the amount of expenditure to be incurred on the activities to be undertaken by the Company;

3. To monitor the CSR policy of the Company from time to time;

4. Any other matter as the CSR Committee may deem appropriate after approval of the Board of Directors or as may be directed by the Board of Directors from time to time. The quorum for the CSR Committee Meeting shall be one-third of its total strength (any fraction contained in that one-third be rounded off as one) or two members, whichever is higher.

The provisions of the SEBI (Listing Obligation and Disclosures) Regulations, 2015 will be applicable to our Companyimmediately upon the listing of Equity Shares of our Company on SME Platform of BSE.

In addition to our Managing Directors whose details have been provided under paragraph above titled ‘Brief Profile of our Directors', set forth below are the details of our Key Managerial Personnel as on the date of filing of this Draft Red Herring Prospectus: Sharanya Nagaraj, aged 27 years is the Chief Financial Officer of our Company. She holds a bachelor's degree in commerce from Bangalore University. In the past, she has been associated with M/s. Abhishek Jain, Chartered Accountant, in the capacity of an intern. She has been associated with our Company since April 12, 2023 in the capacity of head – F&A department and was promoted as the Chief Financial Officer of our Company with effect from January 25, 2024. She has an experience of one year in finance and accounts. She has received a remuneration of 1.44lakhs during the Fiscal 2024, in the capacity of a Chief Financial Officer.

Sapna Parmar, aged 36 years is the Company Secretary and Compliance Officer of our Company. She holds a bachelor's degree in commerce from Bangalore University. She is an associate member of the Institute of Company Secretaries of India. In the past, she has been associated with Sai Sudha Enterprises LLP and has an experience of more than a year in secretarial and compliance industry. She has been associated with our Company since January 25, 2024 and has received a remuneration of 0.89 lakhs during the Fiscal 2024, in the capacity of Company Secretary and Compliance Officer. All our Key Managerial Personnel are permanent employees of our Company.

In addition to our Managing Directors, Chief Financial Officer and Company Secretary and Compliance Officer, whose details have been provided under paragraph above titled ‘Brief Profile of our Directors' and ‘Our Key Managerial Personnel', set forth below are the details of our Senior Managerial Personnel as on the date of filing of this Draft Red Herring Prospectus: Ramya Rangegowdanadoddi Sasale, aged 37 years, is the Admin – Human Resource Department of our Company. She attended APS PU College of Commerce, to pursue pre-university examination degree. She holds a bachelor's degree in commerce from Bangalore University. In the past, she was associated with Southern Star, Hotel Rama Private Limited, in the capacity of an executive in the human resource department. She holds experience of more than nine years in human resource management. She has been associated with our Company since December 1, 2020 and has received remuneration of an amount of 3.06 lakhs in Fiscal 2024.

In addition to the disclosure made under the heading "Relationship between our Directors", none of our Key Managerial Personnel and Senior Management are related to each other or to any of our Directors.

None of the Key Management Personnel and Senior Management hold shareholding in our Company.

None of our Key Managerial Personnel and Senior Management is a party to any bonus or profit sharing plan.

Except as disclosed in this Draft Red Herring Prospectus, no amount or benefit has been paid or given within two preceding years or is intended to be paid or given to any of the Key Managerial Personnel and Senior Management except the normal remuneration for services rendered by them. Additionally, there is no contingent or deferred compensation payable to any of our Key Managerial Personnel and Senior Management.

Except as disclosed in this Draft Red Herring Prospectus, none of our Key Managerial Personnel and Senior Management have any interest in our Company other than to the extent of the remuneration, equity shares held by them or benefits to which they are entitled to as per their terms of appointment and reimbursement of expenses incurred by them during the ordinary course of business. Further, there is no arrangement or understanding with the major shareholders, customers, suppliers or others, pursuant to which any of our Key Managerial Personnel and Senior Management have been appointed.

In addition to the changes specified under "Changes in our Board during the Last Three Years", set forth below, are the changes in our Key Managerial Personnel in the last three years immediately preceding the date of filing of this Draft Red Herring Prospectus:

The attrition of the Key Management Personnel and Senior Management is as per the industry standards.

As on date of this Draft Red Herring Prospectus, our Company does not have any employee stock option plan or purchase schemes for our employees.

Our Company has not granted any loans to the Directors and/or Key Management Personnel and Senior Management as on the date of this Draft Red Herring Prospectus.